BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 16725184)

  • 21. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.
    Cané S; Bignotti E; Bellone S; Palmieri M; De las Casas L; Roman JJ; Pecorelli S; Cannon MJ; O'brien T; Santin AD
    Am J Obstet Gynecol; 2004 Jan; 190(1):60-6. PubMed ID: 14749636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.
    Santin AD; Cane' S; Bellone S; Bignotti E; Palmieri M; De Las Casas LE; Anfossi S; Roman JJ; O'Brien T; Pecorelli S
    Cancer; 2003 Nov; 98(9):1898-904. PubMed ID: 14584072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas.
    De Meyer T; Bijsmans IT; Van de Vijver KK; Bekaert S; Oosting J; Van Criekinge W; van Engeland M; Sieben NL
    J Pathol; 2009 Jan; 217(1):14-20. PubMed ID: 18991331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coordinately up-regulated genes in ovarian cancer.
    Hough CD; Cho KR; Zonderman AB; Schwartz DR; Morin PJ
    Cancer Res; 2001 May; 61(10):3869-76. PubMed ID: 11358798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
    Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
    Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.
    Tone AA; Begley H; Sharma M; Murphy J; Rosen B; Brown TJ; Shaw PA
    Clin Cancer Res; 2008 Jul; 14(13):4067-78. PubMed ID: 18593983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
    Santin AD; Zhan F; Bignotti E; Siegel ER; Cané S; Bellone S; Palmieri M; Anfossi S; Thomas M; Burnett A; Kay HH; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Virology; 2005 Jan; 331(2):269-91. PubMed ID: 15629771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
    Benetkiewicz M; Wang Y; Schaner M; Wang P; Mantripragada KK; Buckley PG; Kristensen G; Børresen-Dale AL; Dumanski JP
    Genes Chromosomes Cancer; 2005 Mar; 42(3):228-37. PubMed ID: 15578687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.
    Collins Y; Tan DF; Pejovic T; Mor G; Qian F; Rutherford T; Varma R; McQuaid D; Driscoll D; Jiang M; Deeb G; Lele S; Nowak N; Odunsi K
    Int J Mol Med; 2004 Jul; 14(1):43-53. PubMed ID: 15202015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
    Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.
    Sawiris GP; Sherman-Baust CA; Becker KG; Cheadle C; Teichberg D; Morin PJ
    Cancer Res; 2002 May; 62(10):2923-8. PubMed ID: 12019173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma.
    Wang X; Wei Z; Gao F; Zhang X; Zhou C; Zhu F; Wang Q; Gao Q; Ma C; Sun W; Kong B; Zhang L
    Anticancer Res; 2008; 28(5B):2991-6. PubMed ID: 19031945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.
    Goto T; Takano M; Sakamoto M; Kondo A; Hirata J; Kita T; Tsuda H; Tenjin Y; Kikuchi Y
    Oncol Rep; 2006 May; 15(5):1265-71. PubMed ID: 16596196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human kallikrein related peptidases 6 and 13 in combination withCA125 is a more sensitive test for ovarian cancer than CA125 alone.
    White NM; Mathews M; Yousef GM; Prizada A; Fontaine D; Ghatage P; Popadiuk C; Dawson L; Doré JJ
    Cancer Biomark; 2009; 5(6):279-87. PubMed ID: 20037204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
    Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.